Babu, Sethu2003-05-222009-06-032003-05-222009-06-032003-05-22Babu S. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha. National Medical Journal of India. 2003 May-Jun; 16(3): 175; author reply 175-6http://imsear.searo.who.int/handle/123456789/118120engAntiviral Agents --economicsCost-Benefit AnalysisDeveloping CountriesDisease ProgressionDrug CostsHepatitis B, Chronic --drug therapyHumansIndiaInterferon-alpha --economicsQuality of LifeTreatment OutcomeComment